Bernicke Wealth Management’s AbbVie ABBV Stock Holding History

Bernicke Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-9,071	Closed	-$731K	–	47
2019 Q1	$731K	Buy	9,071 +560	+7%	+$45.8K	0.46%	39
2018 Q4	$785K	Buy	8,511 +546	+7%	+$48K	0.54%	29
2018 Q3	$753K	Buy	7,965 +750	+10%	+$71.1K	0.5%	39
2018 Q2	$669K	Buy	7,215 +557	+8%	+$54.4K	0.47%	35
2018 Q1	$630K	Sell	6,658 -1,447	-18%	-$159K	0.46%	26
2017 Q4	$784K	Buy	8,105 +429	+6%	+$40.4K	0.59%	15
2017 Q3	$682K	Buy	7,676 +1,021	+15%	+$77.7K	0.53%	17
2017 Q2	$483K	Buy	6,655 +2,406	+57%	+$162K	0.39%	25
2017 Q1	$277K	Buy	+4,249	New	+$267K	0.23%	41

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Bernicke Wealth Management's ABBV Position: Q2 2019 in Review

Bernicke Wealth Management sold out of AbbVie (ABBV) in Q2 2019, closing a stake of 9,071 shares — an estimated $731K sold.

Bernicke Wealth Management first reported a position in ABBV in Q1 2017 and held it in 9 quarters. The position peaked at $785K in Q4 2018. 2,021 funds tracked by Wall St. Rank hold ABBV as of Q2 2019.

Bernicke Wealth Management reported no remaining AbbVie position as of Q2 2019 after selling out during the quarter.
Bernicke Wealth Management sold 9,071 AbbVie shares in Q2 2019, an estimated $731K.
Bernicke Wealth Management first reported a position in AbbVie in Q1 2017 and held it in 9 quarters.
Bernicke Wealth Management's AbbVie position peaked at $785K in Q4 2018.
2,021 funds tracked by Wall St. Rank held AbbVie as of Q2 2019.

Based on Bernicke Wealth Management's 13F filing for Q2 2019, filed 5 Aug 2019.